Archive for 'Home_Spotlight'

MaSTherCell or the future of CMOs

MaSTherCell or the future of CMOs

In an exclusive interview, Hugues Bultot, Chief Executive Officer of MaSTherCell, an emerging pioneer in the industrialization of cell-based therapeutics, based in Gosselies (Belgium) shares with us his vision for the future of the CMO.   [...]

VolitionRx a drop of blood to detect colorectal cancer

VolitionRx a drop of blood to detect colorectal cancer

Belgian Volition – a subsidiary of Volition Rx – is a life sciences company located in Namur (Belgium) focused on developing blood-based diagnostic tests for a broad range of cancer types and other conditions. By bringing [...]

Tools4Patient: design and delivery of personalized pain treatments

Tools4Patient: design and delivery of personalized pain treatments

Tools4Patient, a company founded in 2013 and located in Gosselies (Belgium) is specialized in the development of multimodal companion diagnostics. This creative company recently met its first challenging milestone and thus delivered as planned its first [...]

Nyxoah, awarded for its neurostimulation implant

Nyxoah, awarded for its neurostimulation implant

Nyxoah, a clinical-stage medical device company located in Mont-Saint-Guibert (Belgium), is gaining worldwide recognition as it won the Frost & Sullivan New Product Innovation Leadership Award (2014) as well as the World Technology Award (2014) for [...]

Synolyne Pharma gets new patents granted in Europe and in the US

Synolyne Pharma gets new patents granted in Europe and in the US

Synolyne Pharma, a biotech spin-off company of the University of Liège and spin-out of Kitozyme SA (Belgium), has recently been granted two new patents in both Europe and the United States in relation to its chitosan-based [...]

Delphi Genetics signs international research partnership in the US

Delphi Genetics signs international research partnership in the US

Delphi Genetics S.A., a Walloon SME located in Gosselies (Belgium) partners with US company Avaxia (Lexington, Massachusetts) to develop an improved biomolecules manufacturing and immunization process for Avaxia’s lead product candidate which is in clinical development [...]

ImmunXperts: launch of a unique fully integrated Immunogenicity service provider for biotherapeutics.

ImmunXperts: launch of a unique fully integrated Immunogenicity service provider for biotherapeutics.

ImmunXperts s.a. a start-up located in Gosselies (Belgium) and specializing in the development of proprietary and innovative methods to assess the immunogenicity of novel biotherapeutics and biosimilars has raised USD 1 million in equity and bank [...]

Euroscreen signs a collaboration and licensing agreement with Merck & Co. Inc.

Euroscreen signs a collaboration and licensing agreement with Merck & Co. Inc.

Euroscreen, a Belgian drug discovery and development company providing first-in-class small molecule drug candidates for therapeutics areas such as hormonal disorders, inflammation and neurodegenerative diseases, announced an exclusive world-wide research collaboration and licensing agreement with Merck [...]

Pluriomics raises €4M and settles its production facility in Wallonia!

Pluriomics raises €4M and settles its production facility in Wallonia!

Pluriomics, an emerging biotech company located in Leiden (The Netherlands) and specializing in the delivery of innovative cardiomyocyte models, has raised €4 million in a Series A round to strengthen its R&D and commercial team in [...]

Bone Therapeutics raises EUR 32.2 million through IPO

Bone Therapeutics raises EUR 32.2 million through IPO

Bone Therapeutics – a Walloon cell therapy company specialized in bone fracture repair and prevention – shifts up a gear and raises EUR 32.2 million in a 2.5x oversubscribed successful IPO on Brussels and Paris Euronext [...]